Print

Origen Therapeutics, Inc. Announces Change In Chief Financial Officer And Reports Naked Short Selling To SEC  
10/6/2008 11:19:56 AM

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a leading technology-focused supplier of crop seeds in China, today announced that the company has appointed Yasheng Yang as the Acting Chief Financial Officer effective immediately. Yasheng Yang is replacing Veronica Chen, who is stepping down to pursue other opportunities.
//-->